Prof. Dr. Martin Kerschensteiner

Prof. Dr. Martin Kerschensteiner is a highly experienced clinical neuroimmunologist with extensive experience in the field. His impressive career includes positions at renowned institutions such as Harvard University and LMU Munich. Notably, he is the Managing Director at BMC, Institute for Clinical Neuroimmunology at University Hospital Munich. Dr. Kerschensteiner's work has been recognized with the Sobek Research Prize and membership in the German Academy of Sciences, Leopoldina. With scientific publications focusing on multiple sclerosis and neuroinflammation, his expertise and research are at the forefront of advancing treatments in the field. Dr. Kerschensteiner's unique specialization and extensive publication list showcase his dedication to understanding and treating complex neurological conditions. His research on immune responses, neuroinflammation, and metabolic dysregulation in multiple sclerosis highlights his groundbreaking contributions. Patients at University Hospital Ludwig-Maximilians Munich benefit from his innovative approaches and commitment to advancing clinical neuroimmunology, making him a vital asset in the field.